Clinical Trial Update: Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

View source ↗

Summary

Clinical trial update showing that 18F-DCFPyL is being used to prospectively monitor subjects with biochemically recurrent prostate cancer and the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-DCFPyL (DCFPyL radiotracer for PSMA imaging)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer, Biochemically Recurrent | Status: RECRUITING